000 01421 a2200409 4500
005 20250514080615.0
264 0 _c20031110
008 200311s 0 0 eng d
022 _a0306-5251
024 7 _a10.1046/j.1365-2125.2003.01886.x
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aHempel, Georg
245 0 0 _aPopulation pharmacokinetics of liposomal daunorubicin in children.
_h[electronic resource]
260 _bBritish journal of clinical pharmacology
_cOct 2003
300 _a370-7 p.
_bdigital
500 _aPublication Type: Clinical Trial; Journal Article; Multicenter Study; Randomized Controlled Trial
650 0 4 _aAcute Disease
650 0 4 _aAdolescent
650 0 4 _aAdult
650 0 4 _aAntibiotics, Antineoplastic
_xadministration & dosage
650 0 4 _aChild
650 0 4 _aChild, Preschool
650 0 4 _aDaunorubicin
_xadministration & dosage
650 0 4 _aDrug Carriers
650 0 4 _aHumans
650 0 4 _aInfant
650 0 4 _aInfusions, Intravenous
650 0 4 _aLeukemia, Myeloid
_xdrug therapy
650 0 4 _aLiposomes
650 0 4 _aNeoplasms
_xdrug therapy
650 0 4 _aRecurrence
700 1 _aReinhardt, Dirk
700 1 _aCreutzig, Ursula
700 1 _aBoos, Joachim
773 0 _tBritish journal of clinical pharmacology
_gvol. 56
_gno. 4
_gp. 370-7
856 4 0 _uhttps://doi.org/10.1046/j.1365-2125.2003.01886.x
_zAvailable from publisher's website
999 _c12736384
_d12736384